⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19955330 | 1.00 | — | — | |
| SCHEMBL6360201 | 1.00 | — | — | |
| SCHEMBL257548 | 0.79 | — | — | |
| SCHEMBL24872254 | 0.79 | — | — | |
| SCHEMBL7939568 | 0.79 | — | — | |
| SCHEMBL6355604 | 0.78 | — | — | |
| SCHEMBL19958376 | 0.76 | — | — | |
| SCHEMBL18925970 | 0.76 | — | — | |
| SCHEMBL22747374 | 0.73 | — | — | |
| SCHEMBL22585846 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024130344-A1 | TRANSIENT RECEPTOR POTENTIAL VANILLOID 6 INHIBITORS | UNIQUEST PTY LIMITED (AU) | 2024-06-27 | — | — | WO | disclosed |
| WO-2023229685-A2 | BROAD-SPECTRUM INHIBITORS OF CYTOMEGALOVIRUS | MICROBIOTIX, INC. (US) | 2023-11-30 | — | — | WO | disclosed |
| EP-3371171-B1 | INHIBITORS OF RET | BLUEPRINT MEDICINES CORP (US) | 2023-10-25 | — | — | EP | disclosed |
| EP-3611165-B1 | PYRIDONE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE HAVING THIS AS ACTIVE COMPONENT | MITSUI CHEMICALS CROP & LIFE SOLUTIONS INC (JP) | 2023-08-16 | — | — | EP | disclosed |
| WO-2023098825-A1 | SOS1 INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | 勤浩医药（苏州）有限公司 | 2023-06-08 | — | — | WO | disclosed |
| EP-3613743-B1 | PROCESSES FOR THE PREPARATION OF 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE DERIVATIVES | INTELLIKINE LLC (US) | 2022-03-16 | — | — | EP | disclosed |
| EP-3441392-B1 | A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | INTELLIKINE LLC (US) | 2021-12-15 | — | — | EP | disclosed |
| WO-2021130260-A1 | TETRAHYDROBENZO-QUINOLINE SULFONAMIDE DERIVATIVES USEFUL AS IGE MODULATORS | UCB Biopharma SRL (BE) | 2021-07-01 | — | — | WO | disclosed |
| WO-2021130262-A1 | TETRAHYDROBENZO-QUINOLINE SULFONAMIDES DERIVATIVE COMPOUNDS | UCB Biopharma SRL (BE) | 2021-07-01 | — | — | WO | disclosed |
| EP-3811974-A1 | TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS | Infinity Pharmaceuticals, Inc. (US) | 2021-04-28 | — | — | EP | disclosed |
| EP-2218716-A1 | METHOD FOR AMPLIFYING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2010-08-18 | — | — | EP | disclosed |
| US-7736697-B2 | Atomic layer deposition of tantalum-containing films using surface-activating agents and novel tantalum complexes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-15 | — | — | US | disclosed |
| US-7736697-B2 | Atomic layer deposition of tantalum-containing films using surface-activating agents and novel tantalum complexes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-15 | — | — | US | disclosed |
| EP-2080616-A1 | Planographic printing plate precursor | Fujifilm Corporation (JP) | 2009-07-22 | — | — | EP | disclosed |
| EP-1970373-A1 | ALICYCLIC HETEROCYCLIC COMPOUND | Mitsubishi Tanabe Pharma Corporation (JP) | 2008-09-17 | — | — | EP | disclosed |
| WO-2007019436-A2 | ATOMIC LAYER DEPOSITION OF TANTALUM-CONTAINING FILMS USING SURFACE-ACTIVATING AGENTS AND NOVEL TANTALUM COMPLEXES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-02-15 | — | — | WO | disclosed |
| US-20070036894-A1 | forming tantalum nitride layer or tantalum silicide layer; purity; low temperature process for forming a high quality, uniform tantalum-containing films; useful in integrated circuits as barrier films | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-02-15 | — | — | US | disclosed |
| US-20070036894-A1 | forming tantalum nitride layer or tantalum silicide layer; purity; low temperature process for forming a high quality, uniform tantalum-containing films; useful in integrated circuits as barrier films | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-02-15 | — | — | US | disclosed |
| WO-2007010515-A1 | IMPROVEMENTS TO ANALOGOUS COMPOUNDS OF 6-THIOGUANOSINE TRIPHOSPHATE, THEIR USE IN MEDICAL FIELDS AND PROCESSES FOR THEIR PREPARATION | GIULIANI INTERNATIONAL LIMITED (IE) | 2007-01-25 | — | — | WO | disclosed |
| WO-2003039454-A2 | BETA-SECRETASE INHIBITORS AND METHODS OF USE | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 2003-05-15 | — | — | WO | disclosed |